BU study reveals crucial signaling pathway that drives head and neck cancers

FHS
June 23, 2023
11:45 pm

Despite advances in defining the genomic characteristics of head and neck cancers, these malignancies continue to rank among the deadliest cancers with few targeted therapies available.

Scorpion secures $150m to progress oncology pipeline

The proceeds will be used by the company to advance the clinical development of oncology assets. Credit: Lightspring/Shutterstock. Scorpion Therapeutics has secured $150m in a

July 17, 2024

Dr. Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma – Biotech Investments

EQS-News: Rentschler Biopharma SE / Key word(s): Personnel Dr. Günter Stempfer appointed Site Head Laupheim for Rentschler Biopharma 04.12.2023 / 10:00 CET/CEST The issuer is

December 5, 2023

Baxter completes biopharma solutions sale, business unit revamp

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 revenue: $3.71 billion

November 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.